ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

Atrial fibrillation (AF) is a risk factor for thromboembolic complications, requiring administration of vitamin K antagonists (warfarin) or the new oral anticoagulants (apixaban, dabigatran and rivaroxaban).Aim. To assess the influence of apixaban use on the budget as an alternative to warfarin, dab...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awdur:	A. V. Rudakova
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Столичная издательская компания 2015-09-01
Cyfres:	Рациональная фармакотерапия в кардиологии
Pynciau:	atrial fibrillation warfarin dabigatran rivaroxaban apixaban budget impact analysis
Mynediad Ar-lein:	https://www.rpcardio.online/jour/article/view/89
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!